Home LiteratureArticle Details
PMID: 19955367 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The tumor suppressor p53 transcriptionally regulates cGKI expression during neuronal maturation and is required for cGMP-dependent growth cone collapse.

Tedeschi A, Nguyen T, Steele SU, Feil S, Naumann U, Feil R, Di Giovanni S

Abstract

The cGMP-dependent protein kinase type I (cGKI) has multiple functions including a role in axonal growth and pathfinding of sensory neurons, and counteracts Semaphorin 3A (Sema3A)-induced growth cone collapse. Within the nervous system, however, the transcriptional regulation of cGKI is still obscure. Recently, the transcription factor and tumor suppressor p53 has been reported to promote neurite outgrowth by regulating the gene expression of factors that promote growth cone extension, but specific p53 targets genes that may counteract growth cone collapse have not been identified so far. Here, we show that p53 promotes cGKI expression in neuronal-like PC-12 cells and primary neurons by occupying specific regulatory elements in a chromatin environment during neuronal maturation. Importantly, we demonstrate that p53-dependent expression of cGKI is required for the ability of cGMP to counteract growth cone collapse. Growth cone retraction mediated by Sema3A is overcome by cGMP only in wild-type, but not in p53-null dorsal root ganglia. Reconstitution of p53 levels is sufficient to recover both cGKI expression and the ability of cGMP to counteract growth cone collapse, while cGKI overexpression rescues growth cone collapse in p53-null primary neurons. In conclusion, this study identifies p53 as a transcription factor that regulates the expression of cGKI during neuronal maturation and cGMP-dependent inhibition of growth cone collapse.

MeSH Terms
Animals Animals, Newborn Cells, Cultured Cerebral Cortex/cytology Chlorocebus aethiops Chromatin Immunoprecipitation/methods Cyclic GMP/analogs & derivatives,pharmacology Cyclic GMP-Dependent Protein Kinase Type I Cyclic GMP-Dependent Protein Kinases/deficiency,metabolism Embryo, Mammalian Ganglia, Spinal/cytology Gene Expression Regulation, Developmental/drug effects,genetics,physiology Green Fluorescent Proteins/genetics Growth Cones/drug effects,physiology Mice Mice, Inbred C57BL Mice, Knockout Mutation/genetics Neurons/cytology,drug effects,physiology Organ Culture Techniques RNA, Messenger/metabolism Rats Semaphorin-3A/genetics Transfection/methods Tumor Suppressor Protein p53/deficiency,physiology
Chemicals
RNA, Messenger Semaphorin-3A Tumor Suppressor Protein p53 Green Fluorescent Proteins 8-bromocyclic GMP Cyclic GMP-Dependent Protein Kinase Type I Cyclic GMP-Dependent Protein Kinases Prkg1 protein, mouse Cyclic GMP
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Tedeschi Andrea
Center for Neurology, Laboratory for NeuroRegeneration and Repair, University of Tuebingen, D-72076 Tuebingen, Germany.
Nguyen Tuan
Steele Sonya Ulrike
Feil Susanne
Naumann Ulrike
Feil Robert
Di Giovanni Simone
References (27)
27 references, click to expand
  1. Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation.
    J Biol Chem. 2000 Dec 1;275(48):37829-37 PMID: 10978315
  2. Sp1 transcription factor as a molecular target for nitric oxide-- and cyclic nucleotide--mediated suppression of cGMP-dependent protein kinase-Ialpha expression in vascular smooth muscle cells.
    Circ Res. 2002 Mar 8;90(4):405-12 PMID: 11884369
  3. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.
    J Biol Chem. 2000 Oct 27;275(43):33536-41 PMID: 10922374
  4. Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I.
    J Cell Biol. 2003 Oct 27;163(2):295-302 PMID: 14568994
  5. The receptor guanylyl cyclase Npr2 is essential for sensory axon bifurcation within the spinal cord.
    J Cell Biol. 2007 Oct 22;179(2):331-40 PMID: 17954614
  6. The p53MH algorithm and its application in detecting p53-responsive genes.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8467-72 PMID: 12077306
  7. A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration.
    Cell Death Differ. 2009 Apr;16(4):543-54 PMID: 19057620
  8. Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina.
    Neuroscience. 2005;135(3):863-8 PMID: 16154279
  9. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration.
    EMBO J. 2006 Sep 6;25(17):4084-96 PMID: 16946709
  10. cGMP-dependent protein kinase phosphorylates and inactivates RhoA.
    Biochem Biophys Res Commun. 2001 Jan 26;280(3):798-805 PMID: 11162591
  11. Abnormal neocortical development in mice lacking cGMP-dependent protein kinase I.
    Brain Res Dev Brain Res. 2005 Nov 7;160(1):1-8 PMID: 16154207
  12. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches.
    J Biol Chem. 2001 Nov 23;276(47):43604-10 PMID: 11571296
  13. cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium.
    Circ Res. 2002 Jan 11;90(1):18-20 PMID: 11786513
  14. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones.
    Cell. 1993 Oct 22;75(2):217-27 PMID: 8402908
  15. The specificities of protein kinase inhibitors: an update.
    Biochem J. 2003 Apr 1;371(Pt 1):199-204 PMID: 12534346
  16. The commonly used cGMP-dependent protein kinase type I (cGKI) inhibitor Rp-8-Br-PET-cGMPS can activate cGKI in vitro and in intact cells.
    J Biol Chem. 2009 Jan 2;284(1):556-562 PMID: 19008225
  17. cGMP-mediated signaling via cGKIalpha is required for the guidance and connectivity of sensory axons.
    J Cell Biol. 2002 Nov 11;159(3):489-98 PMID: 12417579
  18. The selectivity of protein kinase inhibitors: a further update.
    Biochem J. 2007 Dec 15;408(3):297-315 PMID: 17850214
  19. Regulation of p53 responses by post-translational modifications.
    Cell Death Differ. 2003 Apr;10(4):400-3 PMID: 12719715
  20. Regulate axon branching by the cyclic GMP pathway via inhibition of glycogen synthase kinase 3 in dorsal root ganglion sensory neurons.
    J Neurosci. 2009 Feb 4;29(5):1350-60 PMID: 19193882
  21. The common and distinct target genes of the p53 family transcription factors.
    Cell Mol Life Sci. 2004 Apr;61(7-8):822-42 PMID: 15095006
  22. Transcriptional control of human p53-regulated genes.
    Nat Rev Mol Cell Biol. 2008 May;9(5):402-12 PMID: 18431400
  23. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides.
    Science. 1998 Sep 4;281(5382):1515-8 PMID: 9727979
  24. Cyclic GMP-dependent neurite outgrowth by genipin and nerve growth factor in PC12h cells.
    Eur J Pharmacol. 2004 Mar 19;488(1-3):35-43 PMID: 15044033
  25. The cGMP-dependent protein kinase--gene, protein, and function.
    Neurochem Res. 1993 Jan;18(1):27-42 PMID: 8385276
  26. Function of cGMP-dependent protein kinases as revealed by gene deletion.
    Physiol Rev. 2006 Jan;86(1):1-23 PMID: 16371594
  27. Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation.
    J Neurosci. 2008 Dec 24;28(52):14202-12 PMID: 19109502
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2009-12-02
Pages
15155-60
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC2822954
Subset
IM
Grants
NINDS NIH HHS · R21 NS052640 · United States
NINDS NIH HHS · R21 NS052640-01A2 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]